Sogen Data · Datasets · 数据专题

甲状腺癌复发轴数据集锦

单细胞 · bulk 转录组

本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。

人源单细胞

Human · Single-cell

  1. 01 GSE184362 对甲状腺癌复发患者的不同组织样本(甲状腺肿瘤、甲状腺旁瘤、转移性淋巴结及皮下转移灶)进行单细胞RNA测序,涵盖未治疗组、碘131消融联合TSH抑制组、全甲状腺切除联合TSH抑制组、半甲状腺切除联合TSH抑制组及多次碘131消融联合TSH抑制组,比较各治疗组与未治疗组间肿瘤微环境的转录组差异。 人源 · 23 例 · GPL24676 · 2021/09/19

    设计对甲状腺癌复发患者的不同组织样本(甲状腺肿瘤、甲状腺旁瘤、转移性淋巴结及皮下转移灶)进行单细胞RNA测序,涵盖未治疗组、碘131消融联合TSH抑制组、全甲状腺切除联合TSH抑制组、半甲状腺切除联合TSH抑制组及多次碘131消融联合TSH抑制组,比较各治疗组与未治疗组间肿瘤微环境的转录组差异。

    摘要The tumor ecosystem of papillary thyroid carcinoma (PTC) is poorly characterized. Using single-cell RNA sequencing, we profiled transcriptomes of 158,577 cells from 11 patients’ paratumors, localized/advanced tumors, initially-treated/recurrent lymph nodes and radioactive iodine (RAI)-refractory distant metastases, covering comprehensive clinical courses of PTC.Our study illuminates a comprehensive landscape of PTC ecosystem that suggests potential prognostic and therapeutic implications. Our work not only adds dimensions to the biological underpinnings of PTC heterogeneity, but also provides a benchmark dataset for this malignancy.

人源bulk 转录组

Human · Bulk RNA-seq

  1. 01 GSE76039 对17例poorly-differentiated甲状腺癌和20例anaplastic甲状腺癌样本进行表达谱分析,比较两组基因表达差异。 人源 · 37 例 · GPL570 · 2016/02/15

    设计对17例poorly-differentiated甲状腺癌和20例anaplastic甲状腺癌样本进行表达谱分析,比较两组基因表达差异。

    摘要BACKGROUND. Poorly-differentiated (PDTC) and anaplastic (ATC) thyroid cancers are rare and frequently lethal tumors, which so far have not been subjected to comprehensive genetic characterization. METHODS. We performed next generation sequencing of 341 cancer genes in 117 PDTCs and ATCs, and a transcriptomic analysis of a representative subset of 37 tumors. Results were analyzed in the context of The Cancer Genome Atlas (TCGA) study of papillary thyroid cancers (PTC). RESULTS. ATCs have a greater mutation burden than PDTCs, and higher mutation frequency of TP53, TERT promoter, PI3K/AKT/mTOR pathway effectors, SWI/SNF subunits and histone methyltransferases. BRAF and RAS are the predominant drivers, and dictate remarkably distinct tropism for nodal vs. distant metastases in PDTC. RAS and BRAF sharply distinguish between PDTCs defined by the Turin (PDTC-Turin) vs. MSKCC (PDTC-MSK) criteria, respectively. Mutations of EIF1AX, a component of the translational preinitiation complex, are markedly enriched in PDTCs and ATCs, and have a striking pattern of co-occurrence with RAS. TERT promoter mutations are rare and subclonal in PTCs, whereas they are clonal and highly prevalent in advanced cancers. Application of the TCGA-derived BRAF-RAS score (a measure of MAPK transcriptional output) shows a preserved relationship with BRAF/RAS mutation in PDTCs, whereas ATCs are BRAF-like irrespective of driver mutation. CONCLUSIONS. These data support a model of tumorigenesis whereby PDTCs and ATCs arise from well-differentiated tumors through the accumulation of key additional genetic abnormalities, many of which have prognostic and possible therapeutic relevance. The widespread genomic disruptions in ATC compared to PDTC underscore their greater virulence and higher mortality.

  2. 02 GSE288945 对16例甲状腺癌患者(5例女性非复发、5例女性复发、3例男性非复发、3例男性复发)的组织样本进行RNA-seq,比较不同性别下复发与非复发状态的转录组差异。 人源 · 16 例 · GPL24676 · 2026/06/30

    设计对16例甲状腺癌患者(5例女性非复发、5例女性复发、3例男性非复发、3例男性复发)的组织样本进行RNA-seq,比较不同性别下复发与非复发状态的转录组差异。

    摘要RNA-seq was used to profile the transcriptomes of 16 patients (8 with non-recurrence and 8 with recurrence). Transcriptome analysis showed that sex differences in gene expression from thyroid cancer patients with and without recurrence. Gene Set Enrichment Analysis (GSEA) revealed TNFa signaling pathway was differentially regulated between male and female patients, providing insights into the complexity of gene expression changes underlying sex disparities.

微信二维码

课题合作 · 扫码加微信

bioinformaticsboy